Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Skip to content
katrin_nink_er1

Seminar Title

 

Seminar N1: Health service reimbursement

Affiliation

Institute for Quality and Efficiency in Health Care (IQWiG)

Country

Germany

1. Current Status, Position

Katrin Nink is currently Head of Division Oncology (Solid Tumours) and Routine Practice Data Collection, Drug Assessment Department, Institute for Quality and Efficiency in health Care (IQWiG) in Cologne.

2. Education

She obtained a Degree in Pharmacy in 1991 from the University of Bonn and worked in various retail pharmacies. She obtained a Master of Public Health in 1998 from the University of Bielefeld and worked in the area of health-related consumer protection at the North-Rhine Westphalian Consumer Centre from 1998 to 2001. She was subsequently employed by the Research Institute of Germany’s largest statutory health insurance fund, AOK (WIdO), her main focus being on drug utilization research. She joined IQWiG in 2012.

3. Research Area

Her main research area is the evidence-based assessment of drugs, i.e., the early benefit assessment of new drugs at market entry, as well as the assessment of established drugs.

4. Conflict of interest

None

 

 

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.